Fluvastatin Prevents Vascular Hyperplasia by Inhibiting Phenotype Modulation and Proliferation Through Extracellular Signal-Regulated Kinase 1 and 2 and p38 Mitogen-Activated Protein Kinase Inactivation in Organ-Cultured Artery

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2004-12-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.ATV.0000152611.50953.e2PMID 15591221
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluvastatin Enhances the Inhibitory Effects of a Selective Angiotensin II Type 1 Receptor Blocker, Valsartan, on Vascular Neointimal Formation

  2003cited by this paper
• Role of JNK, p38, and ERK in Platelet-Derived Growth Factor–Induced Vascular Proliferation, Migration, and Gene Expression

  2003cited by this paper
• Activation of Apoptosis Signal-Regulating Kinase 1 in Injured Artery and Its Critical Role in Neointimal Hyperplasia

  2003cited by this paper
• Decreased Endothelial Nitric-oxide Synthase (eNOS) Activity Resulting from Abnormal Interaction between eNOS and Its Regulatory Proteins in Hypoxia-induced Pulmonary Hypertension*

  2002cited by this paper
• Organ culture as a useful method for studying the biology of blood vessels and other smooth muscle tissues.

  2002cited by this paper
• Statins: the new aspirin?

  2002cited by this paper
• Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy.

  2001cited by this paper
• Inhibitory effect of pentalenolactone on vascular smooth muscle cell proliferation.

  2001cited by this paper
• Statins Alter Smooth Muscle Cell Accumulation and Collagen Content in Established Atheroma of Watanabe Heritable Hyperlipidemic Rabbits

  2001cited by this paper
• Chronic vascular toxicity of doxorubicin in an organ‐cultured artery

  2001cited by this paper
• Increased Store-Operated Ca2+ Entry into Contractile Vascular Smooth Muscle following Organ Culture

  2001cited by this paper
• Gene Transfer of Dominant-Negative Mutants of Extracellular Signal-Regulated Kinase and c-Jun NH2-Terminal Kinase Prevents Neointimal Formation in Balloon-Injured Rat Artery

  2001cited by this paper
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

  2000cited by this paper
• Shiga toxin activates p38 MAP kinase through cellular Ca2+ increase in Vero cells

  2000cited by this paper
• Morphological and functional changes of rabbit mesenteric artery cultured with fetal bovine serum.

  2000cited by this paper
• Current perspectives on statins.

  2000cited by this paper
• Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability.

  2000cited by this paper
• Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk.

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Long-term effects of Ca2+ on structure and contractility of vascular smooth muscle.

  1999cited by this paper
• Impairment of EDR by a long-term PDGF treatment in organ-cultured rabbit mesenteric artery.

  1999cited by this paper
• Long-term effects of Ca(2+) on structure and contractility of vascular smooth muscle.

  1999cited by this paper
• Low-density lipoprotein-independent effects of statins.

  1999cited by this paper
• 3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Attenuate Vascular Smooth Muscle Proliferation by Preventing Rho GTPase-induced Down-regulation of p27 Kip1 *

  1999cited by this paper
• Changes in the Balance of Phosphoinositide 3-Kinase/Protein Kinase B (Akt) and the Mitogen-activated Protein Kinases (ERK/p38MAPK) Determine a Phenotype of Visceral and Vascular Smooth Muscle Cells

  1999cited by this paper
• Differentiated Phenotype of Smooth Muscle Cells Depends on Signaling Pathways through Insulin-like Growth Factors and Phosphatidylinositol 3-Kinase*

  1998cited by this paper
• Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells.

  1998cited by this paper
• 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture.

  1998cited by this paper
• Pharmacological control of the mevalonate pathway: effect on arterial smooth muscle cell proliferation.

  1997cited by this paper
• Coordinate Expression of α-Tropomyosin and Caldesmon Isoforms in Association with Phenotypic Modulation of Smooth Muscle Cells*

  1997cited by this paper
• Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction?

  1996cited by this paper
• Acute hypertension activates mitogen-activated protein kinases in arterial wall.

  1996cited by this paper
• Statins do more than just lower cholesterol.

  1996cited by this paper
• Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study.

  1996cited by this paper
• Stress-activated protein kinases in cardiovascular disease.

  1996cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Regulation of differentiation of vascular smooth muscle cells.

  1995cited by this paper
• Distinct Pathways of G- and G-mediated Mitogen-activated Protein Kinase Activation (*)

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

  1995cited by this paper
• Protein lipidation in cell signaling.

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.

  1993cited by this paper
• The discovery and development of HMG-CoA reductase inhibitors.

  1992cited by this paper
• Activation of the c-Raf protein kinase by protein kinase C phosphorylation.

  1992cited by this paper
• Regulation of the mevalonate pathway

  1990cited by this paper
• The smooth muscle cell in culture.

  1979cited by this paper

• Statin Targeted Treatment Against Intimal Hyperplasia Using Unique Chitosan-PLGA Nanoparticles

  2024cites this paper
• Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases

  2022cites this paper
• Pharmacological prevention of intimal hyperplasia: A state-of-the-art review.

  2022cites this paper
• Gonadal function protects against organ culture-induced vascular damage. Involvement of prostanoids.

  2020cites this paper
• The interplay of membrane cholesterol and substrate on vascular smooth muscle biomechanics.

  2020cites this paper
• Curcumin, a Multifaceted Hormetic Agent, Mediates an Intricate Crosstalk between Mitochondrial Turnover, Autophagy, and Apoptosis

  2020cites this paper
• Statin‐mediated cholesterol depletion exerts coordinated effects on the alterations in rat vascular smooth muscle cell biomechanics and migration

  2020cites this paper
• P38 MAPK Signaling Pathway Mediates Angiotensin II-Induced miR143/145 Gene Cluster Downregulation during Aortic Dissection Formation.

  2017cites this paper
• Effects of Statins and Xuezhikang on the Expression of Secretory Phospholipase A2, Group IIA in Rat Vascular Smooth Muscle Cells.

  2017cites this paper
• Upregulation of 5-Hydroxytryptamine Receptor Signaling in Coronary Arteries after Organ Culture

  2014cites this paper
• Addition of adult serum improves endothelium-dependent relaxation of organ-cultured rat mesenteric artery via inhibiting mitochondrial reactive oxygen species.

  2013cites this paper
• Mitogen-Activated Protein Kinase 14 Is a Novel Negative Regulatory Switch for the Vascular Smooth Muscle Cell Contractile Gene Program

  2013cites this paper
• The Potential Efficacy of R8-Modified Paclitaxel-Loaded Liposomes on Pulmonary Arterial Hypertension

  2013cites this paper
• Chronic treatment with PDGF-BB and endothelin-1 synergistically induces vascular hyperplasia and loss of contractility in organ-cultured rat tail artery.

  2011cites this paper
• [Matrix metalloproteinases and atherosclerosis].

  2011cites this paper
• Metaloproteinazy w miażdżycy naczyń krwionośnych Matrix metalloproteinases and atherosclerosis

  2011cites this paper
• Mechanisms underlying impairment of endothelium-dependent relaxation by fetal bovine serum in organ-cultured rat mesenteric artery.

  2011cites this paper
• Atorvastatin ameliorates tissue damage of obstructed ureter in rats.

  2011cites this paper
• Statins inhibited erythropoietin-induced proliferation of rat vascular smooth muscle cells.

  2010cites this paper
• Simvastatin Ameliorates Rat Cerebrovascular Remodeling During Hypertension via Inhibition of Volume-Regulated Chloride Channel

  2010cites this paper
• The Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic-acid Methyl Ester Has Potent Anti-diabetic Effects in Diet-induced Diabetic Mice and Leprdb/db Mice*

  2010cites this paper
• Static pressure drives proliferation of vascular smooth muscle cells via caveolin-1/ERK1/2 pathway.

  2010cites this paper
• Fluvastatin inhibits mast cell degranulation without changing the cytoplasmic Ca2+ level.

  2009cites this paper
• Simvastatin inhibits cell cycle progression in glucose-stimulated proliferation of aortic vascular smooth muscle cells by up-regulating cyclin dependent kinase inhibitors and p53.

  2008cites this paper
• Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling: role for the urokinase receptor.

  2007cites this paper
• A novel mechanism of action for statins against diabetes-induced oxidative stress

  2007cites this paper
• The Mechanism Underlying Vascular Smooth Muscle Cell Apoptosis Induced by Atorvastatin may be Mainly Associated with Down-regulation of Survivin Expression

  2007cites this paper
• Immunomodulatory effects of statins and autoimmune rheumatic diseases: novel intracellular mechanism involved.

  2006cites this paper
• TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells.

  2006cites this paper
• TGF-β1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells

  2006cites this paper
• Matrix Metalloproteinases and Atherogenesis in Dependence of Age

  2006cites this paper
• Therapy and clinical trials.

  2005cites this paper
• Blood Vessels Simvastatin Ameliorates Rat Cerebrovascular Remodeling during Hypertension via Inhibition of Volume-regulated Chloride Channel Materials and Methods

  year unknowncites this paper